Susquehanna International Group
BTTX

Susquehanna International Group’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Susquehanna International Group’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-36,600
Closed -$26.7K – 13483
2023
Q1 		$26.7K Sell
36,600
-43,300
-54% -$50.9K ﹤0.01% 11960
2022
Q4 		$89.5K Sell
79,900
-58,400
-42% -$86.1K ﹤0.01% 11055
2022
Q3 		$243K Buy
138,300
+40,600
+42% +$74K ﹤0.01% 10344
2022
Q2 		$152K Buy
97,700
+43,800
+81% +$73.3K ﹤0.01% 11007
2022
Q1 		$107K Sell
53,900
-35,100
-39% -$121K ﹤0.01% 11861
2021
Q4 		$414K Buy
+89,000
New +$730K ﹤0.01% 9680

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Susquehanna International Group's BTTX Position: Q1 2024 in Review

Susquehanna International Group sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 38,057 shares — an estimated $7.42K sold.

Susquehanna International Group first reported a position in BTTX in Q3 2021 and held it in 6 quarters. The position peaked at $140K in Q3 2021. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

  • Susquehanna International Group reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 38,057 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.42K.
  • Susquehanna International Group first reported a position in Better Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Susquehanna International Group's Better Therapeutics, Inc. Common Stock position peaked at $140K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.